Troponin and other markers o cardiac damage. Miths and realities;Troponinas y otros marcadores de daño miocárdico. Mitos y realidades

Revista Espanola de Cardiologia

Volumn 56, Issue 1, 2003, Pages 16-19

  Lópezndón, José ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; EDITORIAL; HEART INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MORBIDITY; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

EID: 0037285303     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042336     Document Type: Editorial

References (43)

1. Ellis AK. Serum protein measurements and the diagnosis of acute myocardial infarction. Circulation 1991;83:1107-9.
2. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federdation of Cardiology. World Health Organization Task Force on standardizationof clinical nomenclature. Circulation 1979;59:607-9.
3. López-Sendón J, López de Sá E. Nuevos criterios de diagnóstico de infarto de miocardio: orden en el caos. Rev Esp Cardiol 2001;54:669-74.
4. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CC, Smalling R, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-7.
5. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994;331:561-6.
6. Tsung JS, Tsung SS. Creatine kinase isoenzymes in extracts of various human skeletal muscles. Clin Chem 1986;32:1568-70.
7. Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
8. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
9. Moríñigo JL, Sánchez PL, Martín F, Pabón P, Arribas A, Nieto F, et al. Valor pronóstico tardío de la troponina I en los pacientes ingresados en una unidad coronaria por angina inestable. Rev Esp Cardiol 2003;56:29-34
10. Roldán Torres I, Baello Monge P, Sevilla Toral B, Salvador Sanz A, Salim Martínez M, Peláez González A, et al. Valor pronóstico de la troponina T en pacientes hospitalizados con angina o infarto sin elevación del segmento ST. Rev Esp Cardiol 2003;56: 35-42.
11. Pascual Figal DA, Noguera Velasco JA, Ródenas Checa J, Murcia Alemán T, Martínez Cadenas J, Ferrándiz Gomis R, et al. El dolor torácico en la práctica clínica hospitalaria. Repercusión clínica y asistencial del uso sistemático de troponinas. Rev Esp Cardiol 2003;56:43-8.
12. Bardají A, Bueno H, Fernández-Ortiz A, Heras M. Aplicabilidad de la nueva definición de infarto de miocardio y opinión de los cardiólogos españoles. Rev Esp Cardiol 2003;56:
13. Christenson RH. Biochemical markers of cardiac damage. An overview. Clin Chem 2001;47:431-7.
14. Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtman B, Wiegand U, Kampmann M, et al. Independent prognostic value of troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-7.
15. Jaffe AS. Testing the Wrong Hypothesis: The Failure to Recognize the Limitations of Troponin Assays. J Am Coll Cardiol 2001;38:999-1001.
16. James P, Ellis CJ, Whitlock RM, McNeil AR, Henley J, Anderson NE. Relation between troponin T and mortality ikn patients presenting with an acute stroke. BMJ 2000;320:1502-4.
17. Whyte GP, George K, Sharma S, Lumley S, Gates P. Mckenna WJ. Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc 2000;32:1067-73.
18. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 2001;38:991-8.
19. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953-8.
20. Jaffe AS, Ritter C, Meltzer V, Harter H, Roberts R. Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. J Lab Clin Med 1984;104:193-202.
21. Goodman S, Johnson J, Sullivan J, Steg G, Eagle K, Fox K, et al. What is a myocardial infarction. Analysis of the diagnostic and prognostic impact of adding troponins to the definition of myocardial infarction. J Am Coll Cardiol 2001;71(Suppl A):358.
22. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction 2002. Disponible en: www.americanheart.org
23. van de Werf F, Ardissino D, Betriú A, Cokkinos DV, Flak E, Fox K, et al. Management of acute myocardial infarction in patints with ST elevation. European Society of Cardiology Guidelines Eur Heart J 2002. (en prensa).
24. Bertrand ME, Simoons ML, Fox KAA, Wallentin LW, Hamm CW, McFadden, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology (en prensa). Eur Heart J, 2002. Disponible en: www.escardio.org
25. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) Committee Members. Disponible en: http://www.americanheart.org
26. Arós F, Loma-Osorío A, Alonso A, Alonso JJ, Cabadés A, Coma-Canella I, et al. Guías de actuación clínica de la Sociedad Española de Cardiología en el infarto agudo de miocardio. Rev Esp Cardiol 1999;52:919-56.
27. López Bescós L, Arós Borau F, Lidón Corbi RM, Cequier Fillat A, Bueno H, Alonso JJ, et al. Actualización (2002) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en angina inestable/infarto sin elevación del segmento ST. Rev Esp Cardiol 2002;55:631-42.
28. Grupo de trabajo de la sección de cardiopatía isquémica y unidades coronarias de la Sociedad Española de Cardiología. Unidades de dolor torácico. Organización y protocolos para el diagnóstico de los síndromes coronarios agudos. Rev Esp Cardiol 2002;55:143-54.
29. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-st elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38:478-585.
30. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
31. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia: GUSTO IIA investigators. N Engl J Med 1996;335:1333-41.
32. Ohman EM, Armstrong PW, Weaver WD, Gibler WB, Bates ER, Stebbins AL, et al. Prognostic value of whole-blood qualitative troponin T testing in patients with acute myocardial infarction in the GUSTO-III trial [abstract]. Circulation 1998;96:I-216.
33. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460-5.
34. Sabatine MS, Morrow DA, de Lemos JA, Gibson M, Murphy SA, Rifai N, et al. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes. Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide. Circulation 2002;105:1760-6.
35. López de Sá E, López-Sendón J, Bethencourt A, Bosch X. Pronostic value of clinical variables at presentation in patients with unstable angina or non-Qwave myocardial infarction. Results of the Proyecto de Estudio del Pronóstico de la Angina (PEPA). Circulation 2000;(Suppl II):588-9.
36. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina / non ST elevation myocardial infarction. A method for prognostication and therapeutical decision making. JAMA 2000;284:835-42.
37. Fox KKA, Goodman SG, Klein W, Brieger D, Steg G, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE.) Eur Heart J 2002;23:1177-89.
38. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002;23:1190-201.
39. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 1997;29:43-8.
40. Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 2000;36:1812-7.
41. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999;340:1623-9.
42. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999;354:1757-62.
43. Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation 2001;103:2891-6.